FDA approves hepatitis C drug that costs $1,125 per pill

October 11, 2014 4:06 AM

7 0

FDA approves hepatitis C drug that costs $1,125 per pill

WASHINGTON – Federal health officials have approved a daily pill that can cure the most common form of hepatitis C without the grueling pill-and-injection cocktail long used to treat the virus.

But the drug's $1,125-per-pill price is sure to increase criticism of drugmaker Gilead Sciences, whose pricing strategy for an older hepatitis drug has already drawn scorn from patient groups, insurers and politicians worldwide.

Also read: Synergy Pharma's irritable bowel drug succeeds in key study

Read more

To category page

Loading...